Cargando…

Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer

There is a lack of effective therapeutic drugs in patients with postoperative colorectal cancer (PCRC). This study aimed to investigate the therapeutic effect and mechanisms of Bushen-Jianpi-Jiedu decoction (BSJPJDD) combined with chemotherapeutic drugs (oxaliplatin) on PCRC with liver and kidney yi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Meng-Die, Zhou, Wen-Jun, Chen, Xiao-Le, Chen, Jian, Ji, Qing, Li, Qi, Wang, Wen-Hai, Su, Shi-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020259/
https://www.ncbi.nlm.nih.gov/pubmed/33828479
http://dx.doi.org/10.3389/fphar.2021.524663
_version_ 1783674550464020480
author Yang, Meng-Die
Zhou, Wen-Jun
Chen, Xiao-Le
Chen, Jian
Ji, Qing
Li, Qi
Wang, Wen-Hai
Su, Shi-Bing
author_facet Yang, Meng-Die
Zhou, Wen-Jun
Chen, Xiao-Le
Chen, Jian
Ji, Qing
Li, Qi
Wang, Wen-Hai
Su, Shi-Bing
author_sort Yang, Meng-Die
collection PubMed
description There is a lack of effective therapeutic drugs in patients with postoperative colorectal cancer (PCRC). This study aimed to investigate the therapeutic effect and mechanisms of Bushen-Jianpi-Jiedu decoction (BSJPJDD) combined with chemotherapeutic drugs (oxaliplatin) on PCRC with liver and kidney yin deficiency and spleen deficiency syndrome (LKYD-SDS) through the therapeutic evaluation of clinical therapy and the integrative analysis of network pharmacology, RNA-seq and label-free data, and experiment verification in vitro. In clinical therapy, the median progression-free survival (PFS) and Karnofsky performance score (KPS) were increased in PCRC patients by the aqueous extract of BSJPJDD combined with oxaliplatin treatment for three months, compared to oxaliplatin alone (p < 0.05). The integrative analysis showed that 559 differentially expressed genes (DEGs) and 11 differentially expressed proteins (DEPs) were regulated by BSJPJDD, among which seven bioactive compounds through 39 potential targets were involved in the regulation of multiple signaling pathways including MAPK, PI3K-Akt, and HIF-1, etc. In the experimental verification, an ELISA assay showed that plasma ZEB2, CAT, and KRT78 were decreased, and IL-1Α, CD5L, FBLN5, EGF, and KRT78 were increased in comparison to the above (p < 0.05). Furthermore, the SW620 cell viability was inhibited and the expressions of MAPK and the p-ERK/ERK ratio were significantly downregulated by the aqueous extract of BSJPJDD combined with oxaliplatin treatment, compared with oxaliplatin treatment alone (p < 0.05). These data suggested that BSJPJDD combined with oxaliplatin prolongs the survival and improves Karnofsky performance status of PCRC patients with LKYD-SDS, and may be associated with the regulation of multiple signaling pathways.
format Online
Article
Text
id pubmed-8020259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80202592021-04-06 Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer Yang, Meng-Die Zhou, Wen-Jun Chen, Xiao-Le Chen, Jian Ji, Qing Li, Qi Wang, Wen-Hai Su, Shi-Bing Front Pharmacol Pharmacology There is a lack of effective therapeutic drugs in patients with postoperative colorectal cancer (PCRC). This study aimed to investigate the therapeutic effect and mechanisms of Bushen-Jianpi-Jiedu decoction (BSJPJDD) combined with chemotherapeutic drugs (oxaliplatin) on PCRC with liver and kidney yin deficiency and spleen deficiency syndrome (LKYD-SDS) through the therapeutic evaluation of clinical therapy and the integrative analysis of network pharmacology, RNA-seq and label-free data, and experiment verification in vitro. In clinical therapy, the median progression-free survival (PFS) and Karnofsky performance score (KPS) were increased in PCRC patients by the aqueous extract of BSJPJDD combined with oxaliplatin treatment for three months, compared to oxaliplatin alone (p < 0.05). The integrative analysis showed that 559 differentially expressed genes (DEGs) and 11 differentially expressed proteins (DEPs) were regulated by BSJPJDD, among which seven bioactive compounds through 39 potential targets were involved in the regulation of multiple signaling pathways including MAPK, PI3K-Akt, and HIF-1, etc. In the experimental verification, an ELISA assay showed that plasma ZEB2, CAT, and KRT78 were decreased, and IL-1Α, CD5L, FBLN5, EGF, and KRT78 were increased in comparison to the above (p < 0.05). Furthermore, the SW620 cell viability was inhibited and the expressions of MAPK and the p-ERK/ERK ratio were significantly downregulated by the aqueous extract of BSJPJDD combined with oxaliplatin treatment, compared with oxaliplatin treatment alone (p < 0.05). These data suggested that BSJPJDD combined with oxaliplatin prolongs the survival and improves Karnofsky performance status of PCRC patients with LKYD-SDS, and may be associated with the regulation of multiple signaling pathways. Frontiers Media S.A. 2021-03-22 /pmc/articles/PMC8020259/ /pubmed/33828479 http://dx.doi.org/10.3389/fphar.2021.524663 Text en Copyright © 2021 Yang, Zhou, Chen, Chen, Ji, Li, Wang and Su. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yang, Meng-Die
Zhou, Wen-Jun
Chen, Xiao-Le
Chen, Jian
Ji, Qing
Li, Qi
Wang, Wen-Hai
Su, Shi-Bing
Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
title Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
title_full Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
title_fullStr Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
title_full_unstemmed Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
title_short Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
title_sort therapeutic effect and mechanism of bushen-jianpi-jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020259/
https://www.ncbi.nlm.nih.gov/pubmed/33828479
http://dx.doi.org/10.3389/fphar.2021.524663
work_keys_str_mv AT yangmengdie therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT zhouwenjun therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT chenxiaole therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT chenjian therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT jiqing therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT liqi therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT wangwenhai therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer
AT sushibing therapeuticeffectandmechanismofbushenjianpijiedudecoctioncombinedwithchemotherapeuticdrugsonpostoperativecolorectalcancer